World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
110
Citations
69000
World Ranking
5421
National Ranking
2920

Overview

Brian G.M. Durie is affiliated with Cedars-Sinai Medical Center in the United States, contributing extensively to the fields of medicine, hematology, oncology, and molecular biology. Their research primarily focuses on multiple myeloma and related hematological disorders.

The scientist's main fields of study include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Their subfields of study reflect specialization in:

  • Hematology
  • Molecular Biology
  • Oncology
  • Genetics
  • Pathology and Forensic Medicine

Brian G.M. Durie's research interests cover a variety of topics, including:

  • Multiple Myeloma Research and Treatments
  • Protein Degradation and Inhibitors
  • Chronic Lymphocytic Leukemia Research
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Cancer Treatment and Pharmacology
  • Peptidase Inhibition and Analysis
  • Myeloproliferative Neoplasms: Diagnosis and Treatment

The scientist has contributed to several recent papers, notable examples include:

  • Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group, 2021, The Lancet Oncology
  • International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM), 2020, Blood Cancer Journal
  • Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously untreated multiple myeloma without an intent for immediate autologous stem cell transplant (ASCT), 2020, Blood Cancer Journal
  • Multiple Myeloma Incidence and Mortality Around the Globe; Interrelations Between Health Access and Quality, Economic Resources, and Patient Empowerment, 2020, The Oncologist
  • Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working Group, 2021, The Lancet Oncology

Frequently, Brian G.M. Durie collaborates with other researchers in the domain. Frequent co-authors include:

  • Sigurður Y. Kristinsson
  • Þorvarður Jón Löve
  • Sæmundur Rögnvaldsson
  • Brynjar Viðarsson
  • Páll T. Önundarson

The scientist's publications are commonly found in reputable venues, with the most frequent including:

  • Blood
  • Clinical Lymphoma Myeloma & Leukemia
  • Blood Cancer Journal
  • Journal of Clinical Oncology
  • HemaSphere

Best Publications

  • International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.

    S. Vincent Rajkumar;Meletios A. Dimopoulos;Antonio Palumbo;Joan Blade

  • A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

    Brian G. M. Durie;Sydney E. Salmon

  • International staging system for multiple myeloma.

    Philip R. Greipp;Jesus San Miguel;Brian G.M. Durie;John J. Crowley

  • International uniform response criteria for multiple myeloma

    B. G. M. Durie;J.-L. Harousseau;J. S. Miguel;J. Blade

  • Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

    Robert A. Kyle;J. Anthony Child;Kenneth Anderson;Bart Barlogie

  • International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

    Shaji Kumar;Bruno Paiva;Kenneth C. Anderson;Brian Durie

  • Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

    Antonio Palumbo;Hervé Avet-Loiseau;Stefania Oliva;Henk M. Lokhorst

  • Quantitation of Differential Sensitivity of Human-Tumor Stem Cells to Anticancer Drugs

    Sydney E. Salmon;Anne W. Hamburger;Barbara Soehnlen;Brian G. M. Durie

  • Multiple Myeloma

    Brian G. M. Durie;Gösta Gahrton

  • International Myeloma Working Group molecular classification of multiple myeloma: spotlight review.

    R Fonseca;P L Bergsagel;J Drach;J Shaughnessy

  • Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1

    S. Vincent Rajkumar;Jean Luc Harousseau;Brian Durie;Kenneth C. Anderson

  • Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma

    A. Palumbo;S. V. Rajkumar;M. A. Dimopoulos;P. G. Richardson

  • Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

    S. K. Kumar;J. H. Lee;J. J. Lahuerta;G. Morgan

  • International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

    A. Dispenzieri;R. Kyle;G. Merlini;J. S. Miguel

  • Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

    R A Kyle;B G M Durie;S V Rajkumar;O Landgren

  • Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial

    Brian G.M. Durie;Antje Hoering;Muneer H. Abidi;S. Vincent Rajkumar

  • Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group

    Pieter Sonneveld;Hervé Avet-Loiseau;Sagar Lonial;Saad Usmani

  • Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report

    Antonio Palumbo;Sara Bringhen;Maria Victoria Mateos;Alessandra Larocca

  • Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.

    W. S. Dalton;T. M. Grogan;P. S. Meltzer;R. J. Scheper

  • IMWG consensus on risk stratification in multiple myeloma

    W J Chng;A Dispenzieri;C-S Chim;R Fonseca

Frequent Co-Authors

John Crowley
John Crowley Washington University in St. Louis
Gareth J. Morgan
Gareth J. Morgan Boston University
Pieter Sonneveld
Pieter Sonneveld Erasmus University Rotterdam
Hartmut Goldschmidt
Hartmut Goldschmidt University Hospital Heidelberg
Jesús F. San Miguel
Jesús F. San Miguel University of Navarra
Meletios A. Dimopoulos
Meletios A. Dimopoulos National and Kapodistrian University of Athens
Bart Barlogie
Bart Barlogie Mount Sinai Hospital
Robert Z. Orlowski
Robert Z. Orlowski The University of Texas MD Anderson Cancer Center
Shaji Kumar
Shaji Kumar Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens doors to a wide variety of online degree programs and related health professions. For those interested in healthcare leadership, an affordable mha online can prepare you for administrative roles within hospitals and healthcare systems. These programs offer flexibility for working professionals and are designed to be cost-effective.

If you’re aiming for advanced clinical practice, consider the cheapest dnp online programs. Doctor of Nursing Practice (DNP) degrees are essential for nurses seeking leadership or specialized practitioner positions. Many online options help reduce the burden of tuition costs while maintaining high academic standards.

Those interested in pharmacy can pursue an online pharmacist degree, combining core science training with modern clinical skills. Online pharmacy programs provide flexibility, but ensure your choice meets accreditation and licensure requirements.

For tech-savvy individuals, an online health information management degree can launch a career at the intersection of healthcare, data, and IT. These programs prepare students to manage patient information systems and support efficient healthcare delivery.

Best Scientists Citing Brian G.M. Durie

Trending Scientists

Recently Published Articles